CRIS Current Research Information System

ERCOLANI, GIORGIO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 25.488
NA - Nord America 25.382
EU - Europa 18.540
SA - Sud America 1.510
AF - Africa 1.431
OC - Oceania 42
Continente sconosciuto - Info sul continente non disponibili 9
Totale 72.402
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 25.068
SG - Singapore 7.063
VN - Vietnam 6.652
CN - Cina 5.901
IT - Italia 3.975
GB - Regno Unito 3.428
DE - Germania 2.526
HK - Hong Kong 1.997
NL - Olanda 1.876
SE - Svezia 1.654
IN - India 1.553
FR - Francia 1.118
BR - Brasile 1.099
RU - Federazione Russa 871
IE - Irlanda 653
UA - Ucraina 610
KR - Corea 537
JP - Giappone 423
FI - Finlandia 411
ZA - Sudafrica 381
CI - Costa d'Avorio 356
CH - Svizzera 353
TG - Togo 260
EE - Estonia 255
BG - Bulgaria 178
CA - Canada 165
AR - Argentina 164
PH - Filippine 164
SC - Seychelles 158
AT - Austria 147
JO - Giordania 146
ID - Indonesia 138
BD - Bangladesh 131
TH - Thailandia 127
IQ - Iraq 100
NG - Nigeria 100
MX - Messico 93
TR - Turchia 92
PL - Polonia 90
BE - Belgio 79
ES - Italia 73
PK - Pakistan 69
EC - Ecuador 68
TW - Taiwan 50
SA - Arabia Saudita 48
MY - Malesia 40
UZ - Uzbekistan 40
CL - Cile 39
IR - Iran 38
AU - Australia 36
CO - Colombia 36
GR - Grecia 35
MA - Marocco 31
VE - Venezuela 31
RO - Romania 29
HR - Croazia 28
PE - Perù 28
LT - Lituania 27
PY - Paraguay 26
LB - Libano 25
AE - Emirati Arabi Uniti 24
EG - Egitto 23
KE - Kenya 20
ET - Etiopia 19
IL - Israele 18
PT - Portogallo 18
NP - Nepal 17
GH - Ghana 15
TN - Tunisia 15
AZ - Azerbaigian 14
DZ - Algeria 12
CR - Costa Rica 11
KZ - Kazakistan 11
UY - Uruguay 11
AL - Albania 10
JM - Giamaica 10
PS - Palestinian Territory 10
KH - Cambogia 9
MK - Macedonia 9
RS - Serbia 9
CZ - Repubblica Ceca 8
LU - Lussemburgo 8
MU - Mauritius 8
DK - Danimarca 7
DO - Repubblica Dominicana 7
SK - Slovacchia (Repubblica Slovacca) 7
SN - Senegal 7
BA - Bosnia-Erzegovina 6
HU - Ungheria 6
OM - Oman 6
SI - Slovenia 6
BH - Bahrain 5
BO - Bolivia 5
LI - Liechtenstein 5
NI - Nicaragua 5
NO - Norvegia 5
NZ - Nuova Zelanda 5
QA - Qatar 5
SY - Repubblica araba siriana 5
BY - Bielorussia 4
Totale 72.294
Salva come PNG Salva come JPEG
Città #
Singapore 4.940
Southend 2.958
Fairfield 2.820
Ashburn 2.685
Hong Kong 1.868
Chandler 1.662
Ho Chi Minh City 1.364
Dong Ket 1.321
San Jose 1.246
Woodbridge 1.236
Hanoi 1.122
Wilmington 1.111
Santa Clara 1.078
Hefei 1.053
Seattle 1.007
Houston 966
Cambridge 866
Princeton 785
Beijing 709
Kerkrade 665
Ann Arbor 652
Dublin 598
Boardman 591
Bologna 570
Los Angeles 523
Frankfurt am Main 520
Lauterbourg 443
Seoul 442
Dallas 374
Abidjan 356
Tokyo 353
Munich 339
Eygelshoven 338
Jacksonville 330
Milan 320
Westminster 316
Nanjing 314
Helsinki 305
Council Bluffs 302
Padova 264
Lomé 260
New York 260
Delhi 247
Berlin 237
Buffalo 219
Da Nang 219
Haiphong 204
Bern 201
Florence 201
San Diego 173
Jinan 172
Sofia 168
Shenyang 160
Saint Petersburg 149
Guangzhou 145
Amman 141
Redondo Beach 140
Redmond 139
São Paulo 132
Shanghai 128
Rome 127
Turin 119
Changsha 116
Menlo Park 112
Bengaluru 108
Chicago 105
Nanchang 95
Dearborn 93
Hebei 89
Vienna 89
Amsterdam 88
Tianjin 82
Abeokuta 80
Biên Hòa 80
Nuremberg 80
Jiaxing 79
The Dalles 79
Johannesburg 76
Des Moines 75
Hangzhou 73
Mülheim 73
London 71
Medford 71
Brussels 70
Hải Dương 69
Zhengzhou 69
Falkenstein 66
Jakarta 62
Orem 62
Warsaw 62
Toronto 56
Can Tho 55
Olalla 55
Phoenix 55
Paris 53
Montreal 52
Baghdad 51
Bangkok 49
Chennai 49
Falls Church 48
Totale 46.450
Salva come PNG Salva come JPEG
Nome #
Access to and quality of elective care: a prospective cohort study using hernia surgery as a tracer condition in 83 countries 1.670
[Angiogenic factors and their relation to stage, lymph-node micrometastases and prognosis in patients operated on for gastric cancer] 1.628
Colorectal Cancer Stage at Diagnosis Before vs During the COVID-19 Pandemic in Italy 561
Asbestos: a hidden player behind the cholangiocarcinoma increase? Findings from a case–control analysis 396
A prognostic model for use before elective surgery to estimate the risk of postoperative pulmonary complications (GSU-Pulmonary Score): a development and validation study in three international cohorts 390
Appraisal of disease-specific benefits of minimally invasiveness in surgery of breast cancer liver metastases 351
Association between multimorbidity and postoperative mortality in patients undergoing major surgery: a prospective study in 29 countries across Europe 345
Timing of surgery following SARS‐CoV‐2 infection: an international prospective cohort study 337
Extracorporeal interval support for organ retrieval delivery regional experience with sharing equipe, equipment & expertise to increase conventionally defined as controlled donor pool in time of pandemic 329
A comprehensive analysis on expected years of life lost due to pancreatic cancer 309
Clinical trial: peg-interferon alfa-2b and ribavirin for the treatment of genotype-1 hepatitis C recurrence after liver transplantation 303
Adding Liver Stiffness Measurement to the Routine Evaluation of Hepatocellular Carcinoma Resectability Can Optimize Clinical Outcome 301
Infected pancreatic necrosis: outcomes and clinical predictors of mortality. A post hoc analysis of the MANCTRA-1 international study 291
Monofocal hepatocellular carcinoma: How much does size matter? 283
Laser ablation is superior to TACE in large-sized hepatocellular carcinoma: A pilot case-control study 280
Prognostic criteria for postoperative mortality in 170 patients undergoing major right hepatectomy 269
Characterization of pancreatic ductal adenocarcinoma using whole transcriptome sequencing and copy number analysis by single-nucleotide polymorphism array 267
A new liver transplant priority for patients with hepatocellular carcinoma. 263
Absence of neuroinvasive disease in a liver transplant recipient who acquired West Nile virus (WNV) infection from the organ donor and who received WNV antibodies prophylactically. 257
Adjuvant systemic chemotherapy after putative curative resection of colorectal liver and lung metastases. 254
Antifungal prophylaxis in liver transplant recipients: one size does not fit all 252
Adjuvant, adoptive immunotherapy with tumor infiltrating lymphocytes plus interleukin-2 after radical hepatic resection for colorectal liver metastases: 5-year analysis. 250
Comprehensive surgical intestinal rescue and transplantation program in adult patients: Bologna experience. 246
ANGPT2 and NOS3 polymorphisms and clinical outcome in advanced hepatocellular carcinoma patients receiving sorafenib 241
Surgical therapy for hepatolithiasis: a Western experience. 237
Characterization of pancreatic ductal adenocarcinoma patients using whole-transcriptome sequencing and copy number analysis by SNPs array techniques. 235
The Effect of a Liver Transplant Program on the Outcomes of Resectable Hepatocellular Carcinoma: A Nationwide Multicenter Analysis 234
Anticorpi anti-HLA preformati e Trapianto Combinato Rene-Fegato. Caso clinico. 234
Causes of early acute graft failure after liver transplantation: analysis of a 17-year single-centre experience. 233
Pattern of macrovascular invasion in hepatocellular carcinoma 233
Recalibrating survival prediction among patients receiving trans‐arterial chemoembolization for hepatocellular carcinoma 230
Good survival outcome of metastatic SDH-deficient gastrointestinal stromal tumors harboring SDHA mutations 227
Membrane localization of human equilibrative nucleoside transporter 1 in tumor cells may predict response to adjuvant gemcitabine in resected cholangiocarcinoma patients 225
Whole exome sequencing (WES) on formalin-fixed, paraffin-embedded (FFPE) tumor tissue in gastrointestinal stromal tumors (GIST) 221
Resection line involvement after gastric cancer treatment: handle with care 219
Combined kidney-liver, heart-liver, and kidney-pancreas transplantations from a single deceased donor. 218
Clinical Target Volume in Biliary Carcinoma: A Systematic Review of Pathological Studies. 215
Combined liver–dual kidney transplant: Role in expanded donors 215
An explorative data-analysis to support the choice between hepatic resection and radiofrequency ablation in the treatment of hepatocellular carcinoma. 213
Carbapenem-resistant Klebsiella pneumoniae colonization at liver transplantation:a management challenge 213
Criteria for diagnosing benign portal vein thrombosis in the assessment of patients with cirrhosis and hepatocellular carcinoma for liver transplantation. 213
A Novel Nomogram to Predict the Prognosis of Patients Undergoing Liver Resection for Neuroendocrine Liver Metastasis: an Analysis of the Italian Neuroendocrine Liver Metastasis Database 212
Role of SIRT-3, p-mTOR and HIF-1α in Hepatocellular Carcinoma Patients Affected by Metabolic Dysfunctions and in Chronic Treatment with Metformin 211
Assessment of Radiofrequency Ablation Efficacy for Hepatocellular Carcinoma by Histology and Pre-transplant Radiology 209
Impact of model for end-stage liver disease (MELD) score on prognosis after hepatectomy for hepatocellular carcinoma on cirrhosis. 208
Second surgery or chemotherapy for relapse after radical resection of colorectal cancer metastases. 208
Coping strategies in intestinal transplantation 208
Regret affects the choice between neoadjuvant therapy and upfront surgery for potentially resectable pancreatic cancer 207
Associated benign liver tumors in idiopathic granulomatous hepatitis: a case report 207
Prognostic factors for tumor recurrence after a 12-year, single-center experience of liver transplantations in patients with hepatocellular carcinoma. 207
Percutaneous radiofrequency ablation in intrahepatic cholangiocarcinoma: a retrospective single-center experience 207
Abdominal wall defect repair with biological prosthesis in transplanted patients: single center retrospective analysis and review of the literature 206
Histological recurrent hepatitis C after liver transplantation: Outcome and role of retransplantation. 205
Integrated genomic study of quadruple-WT GIST (KIT/PDGFRA/SDH/RAS pathway wild-type GIST) 205
Changes in the surgical approach to hilar cholangiocarcinoma during an 18-year period in a Western single center 205
Long term follow-up and outcome of liver transplantation for alcoholic liver disease: a single center case-control study 204
Liver transplantation for hepatocellular carcinoma: further considerations on selection criteria. 202
Anatomic variations of intrahepatic bile ducts in a European series and meta-analysis of the literature. 202
Italian experience in adult clinical intestinal and multivisceral transplantation: 6 years later. 202
The changing scenario of hepatocellular carcinoma in Italy: an update 200
Imaging in resectable colorectal liver metastasis patients with or without preoperative chemotherapy: results of the PROMETEO-01 study 200
The role of lymphadenectomy for liver tumors. Further considerations on the appropriateness of treatment strategy 200
Conventional split liver transplantation for two adult recipients: a recent experience in a single European center 198
Competing risk analysis on outcome after hepatic resection of hepatocellular carcinoma in cirrhotic patients. 198
External Validation of Surrogate Indices of Fatty Liver in the General Population: the Bagnacavallo Study 198
GOSAFE - Geriatric Oncology Surgical Assessment and Functional rEcovery after Surgery: early analysis on 977 patients 197
Liver allocation for hepatocellular carcinoma: a European Center policy in the pre-MELD era. 196
Years of Life Lost for Older Patients After Colorectal Cancer Diagnosis 195
Implementation of a patient blood management in an Italian City Hospital: is it effective in reducing the use of red blood cells? 194
Conditional survival after hepatic resection for hepatocellular carcinoma in cirrhotic patients. 194
Induction therapy with Alemtuzumab (Campath) in combined liver-kidney transplantation: University of Bologna experience. 193
Combined heart-liver transplantation: A single-center experience 193
Combined Liver-Kidney Transplantation With Preformed Anti-HLA Antibodies: A Case Report. 193
Metabolic disorders across hepatocellular carcinoma in Italy 193
Assessment of donor steatosis in liver transplantation: is it possible without liver biopsy? 192
Daclizumab and Alemtuzumab as induction agents in adult intestinal and multivisceral transplantation: A comparison of two different regimens on 29 recipients during the early post-operative period. 192
A prospective comparative study between celsior and university of Wisconsin preserving solution in liver transplantation from elderly donors 192
Global 30-day morbidity and mortality of surgery for perforated peptic ulcer: GRACE study 191
Gastric splenosis mimicking a gastrointestinal stromal tumor: A case report 191
EASL Clinical Practice Guidelines on the prevention, diagnosis and treatment of gallstones 190
Discovery of new potentially actionable mutations in pancreatic ductal adenocarcinoma by next generation sequencing 189
Daclizumab and alemtuzumab as induction agents in adult intestinal and multivisceral transplantation: rejection and infection rates in 40 recipients during the early postoperative period. 189
Material deprivation affects the management and clinical outcome of hepatocellular carcinoma in a high-resource environment 189
Efficacy of MELD score in predicting survival after liver retransplantation. 188
Assessment of perioperative transfusion requirement for cirrhotic patients undergoing elective hepatectomy 188
In Reply 188
A prospective multi-center randomized clinical study to compare the efficacy of ertapenem 3 days versus ampicillin-sulbactam 3 days in the treatment of localized community acquired intra-abdominal infection 186
Comparison of recurrence of hepatocellular carcinoma after resection in patients with cirrhosis to its occurrence in a surveilled cirrhotic population. 186
Can the dropout risk of candidates with hepatocellular carcinoma predict survival after liver transplantation? 185
Correction: International consensus on the management of metastatic gastric cancer: step by step in the foggy landscape: Bertinoro Workshop, November 2022 184
Discovery of new potential actionable mutations in pancreatic ductal adenocarcinoma by next generation sequencing 183
High-dose Weekly Liposomal Amphotericin B Antifungal Prophylaxis in Patients Undergoing Liver Transplantation 182
Critical systematic review on hepatic resection and transarterial chemoembolization for hepatocellular carcinoma 181
Using Elderly Donors in Liver Transplantation. 180
Comparison between the fifth and sixth editions of the AJCC/UICC TNM staging systems for hepatocellular carcinoma: multicentric study on 393 cirrhotic resected patients. 180
Kidney transplantation combined with other organs in bologna: an update. 179
Age and equity in liver transplantation: An organ allocation model. 179
Molecular monitoring of organ recipients from cancer-affected donors by detection of circulating tumor cells. 178
Medication compliance after liver transplantation: the importance of family support 178
Effectiveness and cost-effectiveness of peri-operative versus post-operative chemotherapy for resectable colorectal liver metastases. 178
Totale 25.363
Salva come PNG Salva come JPEG
Categoria #
all - tutte 195.587
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 195.587
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20212.547 0 0 0 0 0 0 0 0 0 271 242 2.034
2021/20227.207 652 273 373 523 638 331 163 539 365 370 1.889 1.091
2022/20237.795 724 1.095 419 913 525 590 252 491 1.364 240 735 447
2023/20242.478 192 392 170 269 208 423 148 182 100 169 120 105
2024/202511.909 462 1.521 967 924 1.878 695 863 442 354 789 626 2.388
2025/202626.934 2.084 2.411 2.422 1.894 2.810 3.028 4.077 916 5.375 1.917 0 0
Totale 73.767